3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Completed
6
Unknown
2
Recruiting
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
24
Neoplasm Metastasis
6
Colonic Neoplasms
6
Stomach Neoplasms
5
Rectal Neoplasms
5
Carcinoma, Hepatocellular
4
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Biliary Tract Neoplasms
3
Adenocarcinoma Of Esophagus
3
Unresectable Metastatic Colorectal Cancer
2
Recurrence
2
Neoplastic Cells, Circulating
2
Neoplasms
2
Gastrointestinal Neoplasms
2
Adenocarcinoma
2
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Ovarian Neoplasms
1
Oligometastatic Gastric Adenocarcinoma
1
Neoplasms, Second Primary
1
Neoplasm, Residual
1
Margins of Excision
1
Lung Neoplasms
1
Locally-advanced Rectal Cancer
1
Locally Advanced Colorectal Carcinoma
1
Hyperthermia
1
Gastroesophageal Junction Adenocarcinoma
1
Gastroesophageal Adenocarcinoma
1
Gallbladder Neoplasms
1
Interventions
pembrolizumab
38
Blood Specimen Collection
38
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
17
Exercise
17
Carboplatin
17
Nivolumab
15
atezolizumab
14
Paclitaxel
14
Cisplatin
14
Drug Therapy
13
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
11
Trastuzumab
10
Pemetrexed
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Folfox protocol
×
Clear all
NCT06846346
2026-04-28
GRACIE
UNICANCER
Phase 2
Recruiting
88 enrolled
NCT06475352
2026-04-23
FUDOSE
UNICANCER
Phase 2
Recruiting
400 enrolled